Welcure Drugs & Pharmaceuticals Ltd - WELCURE DRUGS Share Price

Sector: Pharmaceuticals | ISIN: INE331C01017
₹ 4.00 (-1.72%) icon8 Dec, 2023, 12:00:00 AM

Welcure Drugs & Pharmaceuticals Ltd KEY RATIOS

sector: Pharmaceuticals

  • CMP

    as on 12/8/2023 12:00:00 AM

    ₹ 4 -0.07 -1.72
  • Open
  • ₹ 4
  • Prev. Close
  • ₹ 4.07
  • Turnover(Lac.)
  • ₹ 1
  • Day's High
  • ₹ 4.1
  • Day's Low
  • ₹ 4
  • 52 Week's High
  • ₹ 6.42
  • 52 Week's Low
  • ₹ 3.2
  • Book Value
  • ₹ 1.079
  • Face Value
  • ₹ 10
  • Mkt Cap (₹ Cr.)
  • 5.4
  • P/E
  • 0
  • EPS
  • 0
  • Divi. Yield
  • 0

Welcure Drugs & Pharmaceuticals Ltd Corporate Actions

03 Nov , 2023

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

03 Nov , 2023

12:00 AM

04 Sep , 2023

12:00 AM

AGM

Announcement date: 04 Sep , 2023

View Details

04 Sep , 2023

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

04 Aug , 2023

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

04 Aug , 2023

12:00 AM

05 Jul , 2023

12:00 AM

05 Jul , 2023

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

23 May , 2023

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

23 May , 2023

12:00 AM

01 Feb , 2023

12:00 AM

01 Feb , 2023

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

20 Sep , 2023

12:00 AM

BookCloser

View Details

Welcure Drugs & Pharmaceuticals Ltd News and Update

Image not found
  • 1 day ago |
  • 10:15 PM

The move follows Warburg Pincus' complete exit from Computer Age Management Services Ltd (CAMS) earlier this week.

Image not found
Image not found

Invest wise with Expert advice

mobile icon
  • Open Demat with exclusive Advice & Services
  • Get a dedicated Relationship Manager to help you grow your wealth
  • Exclusive advisory on 20+ trading & wealth based investment options
  • One tap Investments, Automated trading & much more
  • Minimum 1 lakh margin required

Welcure Drugs & Pharmaceuticals Ltd SHAREHOLDING SNAPSHOT
08 December , 2023 | 08:40 PM

PROMOTER - TOTAL0.00%

Indian: 0.00%

Foreign: 0%

NON-PROMOTER - TOTAL 100.00%

Institutions: 0.00%

Non-Institutions: 100.00%

CUSTODIES - 0.00%

Custodies: 0.00%

See More Details
ad IconAd Image

Welcure Drugs & Pharmaceuticals Ltd FINANCIALS

No Data Available To Display Chart

Welcure Drugs & Pharmaceuticals Ltd PEER COMPARISON

Figures of Market Capital(Mar Cap), Quaterly Net Profit(NP Qtr) and Quaterly Sales(Sales Qtr) are in ₹ Cr.View All Peer Comparison

MORE ABOUT Welcure Drugs & Pharmaceuticals Ltd

  • Gagan Juneja
  • Non-Exec. & Independent Dir.
  • Mohd. Shahbaz Alam
  • Independent Director
  • Sitaben S Patel
  • Additional Director
  • Rajeev Mehra
  • Additional Director

Summary

Incorporated on 4 Jun.92, Welcure Drugs And Pharmaceuticals (WDPL) was promoted by D C Jain, Sanjeev Jain and Sandeep Jain. The promoters have interests in other companies such as Paam Pharmaceuticals, Pioneer Products, Alirox Abrasives, A K Laboratories, etc. The company is managed by managing director D C Jain.WDPL had come out with a Rs 4-cr public issue in Aug.94 to part-finance the Rs 7-cr project to manufacture bulk drugs in Rajasthan and finance investments in a subsidiary, A K Laboratories (AKL). The company has also submitted the letter of offer for a Rs 7.09-cr rights issue of equity shares in Jan.96 to finance its expansion programmes.Products of WDPL include bulk drugs such as ampicillin and trimethoprim, drugs intermediates and pharmaceutical formulations. It has decided to add amoxycillin and cloxacillin to its range with provision to manufacture ibuprofen. It manufactures over a hundred varieties of tablets, capsules and dry syrups, sulpha drugs, vitamins, analgesics, etc. Its subsidiary, AKL, manufactures 6-APA, a key drug intermediate in the manufacture of semi-synthetic penicillin. The company has decided to set up new sections of paediatrics and veterinary drugs and to diversify into ointments and liquid syrups. The new products of the company WELSTAP , X- CLOX , ETHAMBUTOL, RIFA- Z , CETIRIZIN , NORTIN have been well accepted in the market.The Company has entered into a collaboration agreement with a russian company to act as their sole selling agent for... Read More


Reports by Welcure Drugs & Pharmaceuticals Ltd


Reports by Welcure Drugs & Pharmaceuticals Ltd

Company FAQ

No Record Found